Insights

Select a category below to filter the articles.
prostate 101
AI & imaging
news & updates
VIDEOS
Prostate Cancer Patient and Doctor
Prostate 101
  • September 17, 2026
Will Prostate Cancer Treatment Affect My Sex Life or Bladder Control?
Changes in erections and bladder control are among the most common concerns men have when considering prostate cancer treatment, and they affect partners as well. The risk depends on the treatment, your health and function before treatment, the location and extent of the cancer, and other clinical factors. Prostate MRI can add important information about suspicious areas and disease extent, but MRI does not diagnose cancer or determine treatment by itself. A careful interpretation, together with PSA, biopsy findings and the rest of the clinical picture, can help you and your physicians discuss the options and their trade-offs.
Prostate Cancer Patient and Doctor
Prostate 101
  • August 17, 2026
Elevated PSA, Normal MRI: What Happens Next?
A prostate MRI that shows nothing suspicious is reassuring, but it does not by itself explain an elevated PSA. This article covers what "clinically significant" prostate cancer means and why MRI is aimed at it, the many non-cancer reasons PSA can rise, what a negative scan lowers and what it leaves open, and what physicians weigh next: PSA trend, PSA density, digital rectal exam, family and genetic history, prior biopsies, and biomarker testing. It also explains why the technical quality of the scan is part of the picture.
Prostate Cancer Patient and Doctor
Prostate 101
  • August 17, 2026
What "Clinically Significant" Prostate Cancer Actually Means
"Clinically significant" appears in MRI reports and biopsy results without anyone explaining it. It describes prostate cancer likely to grow, spread, or cause harm, as opposed to cancer that may never do either. That judgment rests mostly on grade. The two numbers in a Gleason score tell you which growth patterns are present and which one dominates, which is why 3+4 and 4+3 total the same yet mean different things. Grade Group 2 and above is generally treated as significant, though the line is debated and depends on the patient.
Prostate Cancer Patient and Doctor
Prostate 101
  • August 12, 2026
How to Get a Copy of Your Own Prostate MRI
If you have had a prostate MRI, you have a legal right to receive a copy of it. That right covers more than the written report. The actual image files, stored in a format called DICOM, are part of your health record too, and they are what another radiologist or a second-opinion service needs in order to look at your scan again. This article explains the difference between the report and the images, who to contact at the imaging center, what to say when you ask, how long the process should take in the U.S., EU, and UK, what you can reasonably be charged, what to do if you are refused or delayed, and which free software will open the files once they arrive.
Prostate Cancer Patient and Doctor
Prostate 101
  • August 4, 2026
What Information Can an MRI Provide That a PSA Test Cannot?
A PSA test gives one number for the whole prostate, and it can rise for reasons that have nothing to do with cancer. An MRI looks at the gland itself: where a suspicious area sits, how large it is, and how the tissue behaves. Neither test confirms cancer on its own. Understanding what each one contributes can make your next conversation with your physician a clearer one.
Prostate Cancer Patient and Doctor
Prostate 101
  • July 5, 2026
Why Lesion Location Matters
When a prostate MRI report describes a lesion, most patients focus on whether it looks suspicious. But *where* the lesion sits inside the prostate is one of the first things radiologists evaluate, and it can shape how a finding is interpreted, how a biopsy might be planned, and what questions are worth raising with your care team. The prostate is divided into several regions, each with its own anatomy and its own challenges on MRI. This article explains those regions in plain language, why location influences an MRI suspicion score, and where a second, AI-supported review of a scan can fit into the picture. Location is only one piece of a larger clinical assessment, and no single detail on an MRI diagnoses or rules out cancer on its own.
AI & Imaging
  • August 22, 2026
New UCL Research: Could a Prostate MRI Replace a Biopsy?
Four experienced radiologists at UCL and UCLH re-read 251 suspicious prostate MRIs and recorded how sure they felt about each one. When they said "99% sure," they were right. Every man in that group who went on to biopsy had clinically significant cancer. That level of certainty applied to only about 1 in 10 men coming through the clinic, and the authors call their findings hypothesis-generating. It still raises a question worth asking your doctor: how much is your MRI already telling you?
AI & Imaging
  • July 23, 2026
Why More Patients Are Getting an MRI Before Their First Biopsy
Prostate MRI is increasingly used before an initial biopsy because it can show suspicious areas, estimate prostate volume, and help physicians plan more targeted tissue sampling. In some patients with a reassuring MRI and a low-risk overall picture, it may also support a discussion about monitoring rather than biopsying immediately. MRI does not diagnose prostate cancer, and a negative result does not reduce the risk to zero. Decisions still depend on PSA information, personal risk factors, scan quality, physician judgment, and patient preferences. Guidance also differs between the United States, Europe, and the UK, which is one reason two men with similar results can receive different advice.
AI & Imaging
  • June 23, 2026
Prostate Cancer Is on the Rise. A Faster MRI Could Help More Men Get Answers.
Prostate cancer is now the most commonly diagnosed cancer in the United States and is rising about 3% a year. MRI has reshaped how it is evaluated, helping target biopsies and, for some men, avoid one. A shorter, contrast-free version of the scan called biparametric MRI (bpMRI) performed about as well as the longer multiparametric scan (mpMRI) in a large 2025 trial, while taking roughly half the time and costing far less. AI tools are also being studied to help radiologists read these scans more consistently. Together these advances could help more men get timely, accurate answers, though every scan and result still belongs in a conversation with a physician.
AI & Imaging
  • June 18, 2026
What Does Your Prostate Size Actually Tell Your Doctor?
Prostate size can play an important role in how doctors interpret PSA levels, evaluate urinary symptoms, calculate PSA density, and plan biopsies. This article explains why prostate volume matters, how MRI and AI-supported segmentation can provide more precise measurements, and why a more accurate understanding of prostate size can help patients and physicians make more informed decisions.
Prostate 101
  • June 12, 2026
What Type of AI Is Reviewing Your Prostate MRI?
When people hear "artificial intelligence," they often think of chatbots, robots, or computers that think like humans. But the AI used in prostate MRI analysis is something very different. It belongs to a category called Narrow AI. In this article, we'll explore the three major types of AI based on ability and explain where prostate MRI analysis fits.
AI & Imaging
  • March 19, 2026
Understanding Your PI-RADS Score
PI-RADS is the standardized scoring system used to interpret prostate MRI—but what do those scores really mean for your cancer risk and next steps? This guide breaks down the 1–5 scale, explains the difference between mpMRI and bpMRI, and clarifies common misconceptions—especially around the “gray zone” of PI-RADS 3. Understanding your score can reduce anxiety, improve decision-making, and help you have more informed conversations with your care team.
News & Updates
  • September 24, 2026
How Often Do Men Get an MRI Before a Prostate Biopsy? What New U.S. Data Show
A new research letter in JAMA Oncology looked at more than 505,000 prostate biopsies at U.S. hospitals from 2017 to mid-2026. Among men having their first biopsy, the share who had an MRI beforehand rose from about 14% to about 64%. An earlier study using insurance claims found that roughly 1 in 3 biopsies were preceded by MRI in 2022. The two studies used different data and methods, so their numbers can't be lined up exactly. Together, they show that MRI before biopsy has become much more common in the U.S., with differences that remain, including between Black and White patients. If a biopsy has been recommended, it is reasonable to ask your doctor whether an MRI is part of your plan and why.
6 min read
News & Updates
  • March 30, 2026
Precision Prostate Consulting Rebranded as DeepView Imaging
Precision Prostate Consulting, LLC (PPC), a leader in AI-powered prostate MRI analysis, today announced its official rebrand to DeepView Imaging. The new name reflects the company’s direct-access platform and its expanding mission to democratize access to fast, AI-powered second opinions for prostate MRI, delivering actionable imaging insights when patients need them most.
3 min read
News & Updates
  • February 23, 2026
Jamie Richgels Joins PPC as Managing Partner
Precision Prostate Consulting, LLC (PPC), a provider of AI-powered prostate cancer detection and diagnostic services, today announced the appointment of Jamie Richgels as Managing Partner. In this role, Richgels will lead the company’s strategic and technological growth initiatives while advancing PPC’s mission to expand access to high-quality prostate cancer diagnostics.“We are thrilled to welcome Jamie to the PPC leadership team,” said Dr. Randall W. Jones, PhD., Managing Partner of Precision Prostate Consulting.“
2 min read
What Should Every Man Do Before Age 50?

Prostate health shouldn’t become a concern only when you reach your 50s or 60s.

Dr. Eric Walser makes the case for starting long before there is an elevated PSA, an MRI, or a prostate cancer diagnosis.

Healthy habits such as staying active, maintaining a healthy weight, not smoking, managing blood pressure, and eating a balanced diet are important for overall health. Research also suggests that some of these habits may be associated with a lower risk of aggressive or fatal prostate cancer.

Of course, lifestyle is only part of the picture. Age, family history, genetics, and ancestry can also affect prostate cancer risk.

Watch the short clip and share your thoughts: Did prostate health become something you thought about only later in life, or was it already on your radar?

I'm Worried About Prostate Cancer, What Should I do?

Worried about prostate cancer? A few steadying words from Dr. Eric Walser.

An elevated PSA or a recommended prostate MRI can be unsettling. In this video, Dr. Eric Walser, a recognized authority in minimally invasive, image-guided treatment for prostate cancer and former Professor & Chairman of Radiology at the University of Texas, shared two ideas worth holding onto.

First, don't be afraid of the MRI. Some men avoid it because of claustrophobia, but scans have gotten shorter and mild sedation is often available. What matters is the information the scan provides, which can help patients and their doctors avoid unnecessary biopsies and treatment.

Second, seek more than one opinion. After a biopsy or a diagnosis, different specialists may recommend different paths, and that can feel overwhelming. Dr. Walser points out that many men accept the first recommendation and undergo aggressive treatment they may not have needed. Talking with several doctors, often alongside a partner, can lead to a decision you feel comfortable with.

A prostate MRI holds a great deal of information, and a careful second look at that same scan can sometimes add useful perspective. DeepView Imaging offers an FDA-cleared AI-supported second analysis of a prostate MRI you already have, giving you and your care team another perspective to discuss, typically within 30 minutes. A second opinion can help confirm the initial interpretation or highlight additional areas of interest. It does not replace your radiologist or treating physician.

The decisions are yours to make, guided by the doctors who know your case.

‍

News & Updates
  • September 24, 2026
How Often Do Men Get an MRI Before a Prostate Biopsy? What New U.S. Data Show
A new research letter in JAMA Oncology looked at more than 505,000 prostate biopsies at U.S. hospitals from 2017 to mid-2026. Among men having their first biopsy, the share who had an MRI beforehand rose from about 14% to about 64%. An earlier study using insurance claims found that roughly 1 in 3 biopsies were preceded by MRI in 2022. The two studies used different data and methods, so their numbers can't be lined up exactly. Together, they show that MRI before biopsy has become much more common in the U.S., with differences that remain, including between Black and White patients. If a biopsy has been recommended, it is reasonable to ask your doctor whether an MRI is part of your plan and why.
Couple with Doctor Discussing Prostate Cancer Risks & Treatment
Prostate 101
  • September 17, 2026
Will Prostate Cancer Treatment Affect My Sex Life or Bladder Control?
Changes in erections and bladder control are among the most common concerns men have when considering prostate cancer treatment, and they affect partners as well. The risk depends on the treatment, your health and function before treatment, the location and extent of the cancer, and other clinical factors. Prostate MRI can add important information about suspicious areas and disease extent, but MRI does not diagnose cancer or determine treatment by itself. A careful interpretation, together with PSA, biopsy findings and the rest of the clinical picture, can help you and your physicians discuss the options and their trade-offs.
Prostate 101
  • August 17, 2026
Elevated PSA, Normal MRI: What Happens Next?
A prostate MRI that shows nothing suspicious is reassuring, but it does not by itself explain an elevated PSA. This article covers what "clinically significant" prostate cancer means and why MRI is aimed at it, the many non-cancer reasons PSA can rise, what a negative scan lowers and what it leaves open, and what physicians weigh next: PSA trend, PSA density, digital rectal exam, family and genetic history, prior biopsies, and biomarker testing. It also explains why the technical quality of the scan is part of the picture.
AI & Imaging
  • August 22, 2026
New UCL Research: Could a Prostate MRI Replace a Biopsy?
Four experienced radiologists at UCL and UCLH re-read 251 suspicious prostate MRIs and recorded how sure they felt about each one. When they said "99% sure," they were right. Every man in that group who went on to biopsy had clinically significant cancer. That level of certainty applied to only about 1 in 10 men coming through the clinic, and the authors call their findings hypothesis-generating. It still raises a question worth asking your doctor: how much is your MRI already telling you?
Prostate 101
  • August 17, 2026
What "Clinically Significant" Prostate Cancer Actually Means
"Clinically significant" appears in MRI reports and biopsy results without anyone explaining it. It describes prostate cancer likely to grow, spread, or cause harm, as opposed to cancer that may never do either. That judgment rests mostly on grade. The two numbers in a Gleason score tell you which growth patterns are present and which one dominates, which is why 3+4 and 4+3 total the same yet mean different things. Grade Group 2 and above is generally treated as significant, though the line is debated and depends on the patient.
Prostate 101
  • August 12, 2026
How to Get a Copy of Your Own Prostate MRI
If you have had a prostate MRI, you have a legal right to receive a copy of it. That right covers more than the written report. The actual image files, stored in a format called DICOM, are part of your health record too, and they are what another radiologist or a second-opinion service needs in order to look at your scan again. This article explains the difference between the report and the images, who to contact at the imaging center, what to say when you ask, how long the process should take in the U.S., EU, and UK, what you can reasonably be charged, what to do if you are refused or delayed, and which free software will open the files once they arrive.
Upload Your MRI
Upload Your MRI
©
2026
DeepView Imaging.
DeepView Imaging is a service of Precision Prostate Consulting, LLC.
All rights reserved.
Privacy Policy
Service Policy
Designed by Kindred Branding